About Avigna Pharmaceuticals
Avigna Pharmaceuticals is a Healthcare company based in Bengaluru (India). Avigna Pharmaceuticals develops and manufactures APIs and specialty chemicals as a contract provider. It operates on a B2B model. Its Indian entity Avigna Chemitech Private Limited reported revenue of ₹29.16 Cr. Its focus areas include Pharmaceuticals, API Manufacturing and Specialty Chemicals. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Avigna Pharmaceuticals avigna pharmaceuticals develops and manufactures apis and specialty chemicals as a contract provider through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and specialty chemicals. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Bengaluru, India
- SectorsHealthcare
- Website avignapharma.com
- Legal Name Avigna Chemitech Private Limited
- Date of Incorporation 11 Mar, 2005
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹29.16 Cr
FY 2022 · -16% YoY
- Net Loss-₹5.90 Cr
FY 2022 · -20% margin
- EBITDA₹4.46 Cr
FY 2022 · 15% margin
Associated legal entities of Avigna Pharmaceuticals
Avigna Pharmaceuticals is associated with 2 registered companies on The Company Check; the primary company is Avigna Chemitech Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avigna Chemitech Private Limited CIN U24231KA2005PTC035805 | Active | 11 Mar 2005 | Bangalore, Karnataka | ₹29.2 Cr | – | 3 | View details |
| Stellence Pharmscience Private Limited CIN U85110KA1992PTC012673 | Under Cirp | 01 Jan 1992 | Bangalore, Karnataka | ₹29.2 Cr | 103 | 6 | View details |
Board of directors of Avigna Chemitech Private Limited (Avigna Pharmaceuticals)
Avigna Chemitech Private Limited is the primary company behind Avigna Pharmaceuticals. The boards of the 2 registered companies of Avigna Pharmaceuticals currently have 6 directors; the longest-serving is Ramachandran Radhakrishnan, appointed in 2006. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramachandran Radhakrishnan DIN 00326368 | Managing Director | 23 Aug 2006 | 20 yrs 1 mo | Stellence Pharmscience Private Limited, Avigna Chemitech Private Limited |
| Francis Pinto DIN 01844138 | Director | 23 Aug 2006 | 20 yrs 1 mo | Avigna Chemitech Private Limited |
| Anuradha Ramachandran DIN 00326388 | Director | 15 May 2019 | 7 yrs 5 mo | Stellence Pharmscience Private Limited, Avigna Chemitech Private Limited |
| Akash Mathur DIN 06883085 | Director | 01 Apr 2020 | 6 yrs 6 mo | Stellence Pharmscience Private Limited |
| Lalit Kumar Yadav DIN 07874159 | Director | 01 Apr 2020 | 6 yrs 6 mo | Stellence Pharmscience Private Limited |
| Naveen Kumar Jain DIN 02478555 | IRP/RP/Liquidator | 16 Jul 2024 | 2 yrs 2 mo | Stellence Pharmscience Private Limited |
Financials of Avigna Pharmaceuticals
Figures of Avigna Chemitech Private Limited, the primary company behind Avigna Pharmaceuticals, for FY 2022. Revenue was ₹29.16 Cr (-16% year on year). Net loss was -₹5.90 Cr (-20% margin). EBITDA was ₹4.46 Cr (15% margin). Revenue has grown at a compounded annual rate of +23% over three years and -8% over five years.
- ₹29.16 CrRevenue · FY 2022 · -16% YoY
- -₹5.90 CrNet loss · -20% margin
- ₹4.46 CrEBITDA · 15% margin
- ₹6.27 CrPaid-up capital
- +23%Revenue CAGR, 3 years
- -8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Avigna Chemitech Private Limited are on its company page.
Detailed financial statements for Avigna Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Avigna Pharmaceuticals
Avigna Pharmaceuticals has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Avigna Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Avigna Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avigna Pharmaceuticals
Avigna Pharmaceuticals is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind Avigna Pharmaceuticals, Avigna Chemitech Private Limited, reported revenue of ₹29.16 Cr for FY 2022, down 16% year on year.
Avigna Pharmaceuticals avigna pharmaceuticals develops and manufactures apis and specialty chemicals as a contract provider through providing healthcare solutions, producing pharmaceutical products, api manufacturing, and specialty chemicals. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Avigna Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Avigna Pharmaceuticals is associated with 2 legal entities: Avigna Chemitech Private Limited, Stellence Pharmscience Private Limited.
The legal entities of Avigna Pharmaceuticals currently have 7 directors, including Naveen Kumar Jain, Ramachandran Radhakrishnan, Anuradha Ramachandran and others.